Search Within

Hiram S Cody III

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (1)
  3. Miscellaneous (1)
Groups
  1. Epidemiology and Biostatistics (4)
  2. Josie Robertson Surgery Center (4)
  3. Sloan Kettering Institute Postdocs (4)
  4. Surgery (4)
  5. Survivorship Research (4)
  6. GME, Surgery (3)

More Groups

People
  1. Kimberly Van Zee (4)
  2. Laurie Kirstein (4)
  3. Monica Morrow (4)
  4. Audree Tadros (3)
  5. Kate Pawloski (3)
  6. Regina Matar (3)

More People

Years
  1. 2021 (3)
  2. 2017 (1)
Publications
  1. Annals of Surgical Oncology (3)
  2. Annals of Surgery (1)
Publishers
  1. Springer (3)
  2. Lippincott Williams & Wilkins (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASO Visual Abstract: Post-discharge non-steroidal anti-inflammatory drugs are not associated with risk of hematoma after lumpectomy and sentinel lymph node biopsy with multimodal analgesia
    Miscellaneous

    Pawloski, K. R.; Matar, R.; Sevilimedu, V.; Tadros, A. B.; Kirstein, L. J.; Cody, H.; Van Zee, K. J.; Morrow, M.; Moo, T. A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Postdischarge nonsteroidal anti-inflammatory drugs are not associated with risk of hematoma after lumpectomy and sentinel lymph node biopsy with multimodal analgesia
    Journal Article

    Pawloski, K. R.; Matar, R.; Sevilimedu, V.; Tadros, A. B.; Kirstein, L. J.; Cody, H. S.; Van Zee, K. J.; Morrow, M.; Moo, T. A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Routine perioperative and post-discharge use of non-steroidal anti-inflammatory drugs: What is the risk of hematoma after lumpectomy and sentinel lymph node biopsy?
    Meeting Abstract

    Pawloski, K. R.; Matar, R.; Sevilimedu, V.; Tadros, A. B.; Kirstein, L.; Cody, H.; Van Zee, K.; Morrow, M.; Moo, T. A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Axillary dissection and nodal irradiation can be avoided for most node-positive Z0011-eligible breast cancers: A prospective validation study of 793 patients
    Journal Article

    Morrow, M.; Van Zee, K. J.; Patil, S.; Petruolo, O.; Mamtani, A.; Barrio, A. V.; Capko, D.; El-Tamer, M.; Gemignani, M. L.; Heerdt, A. S.; more...
    Annals of Surgery (2017)

    Fulltext@MSK | Save